Savara Inc.

Savara is a drug development company that is working on treatments for rare lung diseases. Its main focus is a medicine called molgramostim that patients would inhale to treat a condition called autoimmune pulmonary alveolar proteinosis, a disease where the lungs fill with a protein-like substance that makes it hard to breathe. The company is currently in the late stages of testing this drug to see if it is safe and works in patients. Savara was founded in 2007 and is based in Pennsylvania.